Proxy Votes Now

Home › Funds › WisdomTree › WisdomTree U.S. SmallCap Fund

WisdomTree U.S. SmallCap Fund (EES) proxy voting record 2025-2026

Fund family: WisdomTree · Filed by WisdomTree Trust (CIK 1350487) · SEC series S000015507

Ticker: EES (C000042153)

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 7,484 with, 22 against, 0 abstentions (not counted as with management); 1 items carried no recommendation. Shareholder proposals: 6 FOR, 10 AGAINST, 0 abstained, by the filing’s own vote-source field.

Compared with WisdomTree as a whole

The same two figures as WisdomTree’s manager page (291,199 ballot items across 70 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsWisdomTreeItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)89.2%7,29491.6%236,396
Backed environmental and social shareholder proposals at US companiesn/a40.1%1,437

Where this fund voted differently from most WisdomTree funds

Each ballot item this fund voted is set against the votes of the other WisdomTree funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted the same way as most WisdomTree funds on all 1,593 items where a comparison was possible.

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 94.9% of this fund’s 7,506 such votes could be given a sector; the other 382 (5.1%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Finance2,00900.0%
Consumer Discretionary1,550130.8%
Technology86510.1%
Health Care78340.5%
Industrials72830.4%
Real Estate33000.0%
Energy28500.0%
Utilities15400.0%
Consumer Staples14910.7%
Telecommunications11600.0%
Miscellaneous11100.0%
Basic Materials4400.0%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections5,2056
Say-on-Pay9232
Audit-related8410
Compensation2640
Corporate Governance1799
Extraordinary Transactions1070
Capital Structure501
Shareholder Rights and Defenses220
Environment or Climate44
Other10

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
Venture Global, Inc.May 27, 2026$10M80
Organon & Co.June 9, 2026$6M130
Matson, Inc.April 23, 2026$6M90
RingCentral, Inc.December 31, 2025$5M80
Harley-Davidson, Inc.May 21, 2026$5M121
Virtu Financial, Inc.June 10, 2026$5M50
Bread Financial Holdings, Inc.May 19, 2026$5M120
BGC Group, Inc.November 12, 2025$4M80

Notable votes against management

MeetingCompanyProposalFundMgmt
May 21, 2026Harley-Davidson, Inc.To vote on a shareholder proposal regarding a climate transition plan. Shareholder proposalAgainstFor
April 22, 2026Levi Strauss & Co.Shareholder proposal, if properly presented at the meeting, requesting Bylaw Amendment related to Sustainability ROI Report by Audit Committee. Shareholder proposalAgainstFor
May 14, 2026The Western Union CompanyStockholder proposal regarding stockholder right to act by written consent Shareholder proposalAgainstFor
June 10, 2026Columbia Sportswear CompanyShareholder proposal regarding proxy access. Shareholder proposalForAgainst
April 24, 2026ArcBest CorporationA shareholder proposal to approve GHG emissions reduction targets, if properly presented at the Annual Meeting. Shareholder proposalAgainstFor
June 9, 2026Pacira Biosciences, Inc.Election of three Class III directors to our board of directors to serve until the 2029 annual meeting of stockholders and until their successors are duly elected and qualified: Company Nominees: DOMA Nominees Opposed by the Company: Oliver Benton Curtis III Shareholder proposalWithholdFor
June 9, 2026Pacira Biosciences, Inc.Election of three Class III directors to our board of directors to serve until the 2029 annual meeting of stockholders and until their successors are duly elected and qualified: Company Nominees: DOMA Nominees Opposed by the Company: Eric de Armas Shareholder proposalWithholdFor
December 15, 2025UniFirst CorporationTo elect two Class II directors, each to serve for a term of three years until the 2029 annual meeting of shareholders and until their respective successors are duly elected and qualified: Arnaud Ajdler Shareholder proposalWithholdFor
December 15, 2025UniFirst CorporationTo elect two Class II directors, each to serve for a term of three years until the 2029 annual meeting of shareholders and until their respective successors are duly elected and qualified: Michael A. Croatti Shareholder proposalForAgainst
May 20, 2026The Wendy's CompanyStockholder proposal regarding a restriction on "blank-check" preferred stock, if properly presented at the Annual Meeting. Shareholder proposalAgainstFor
May 7, 2026Wolverine World Wide, Inc.Shareholder proposal regarding new climate change polices or practices. Shareholder proposalAgainstFor
September 3, 2025Under Armour, Inc.To vote on a stockholder proposal, if properly presented at the Annual Meeting. Shareholder proposalAgainstFor

Contested meetings

Meetings with a proxy contest or competing nominees (6 in 2025-2026), and how the fund voted the items on its ballot.

Search this fund’s votes by company

7,596 ballot items at 947 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, WisdomTree U.S. SmallCap Fund (EES) voted at 947 shareholder meetings of 905 companies, on 7,596 ballot items in all. Where management made a recommendation, the fund followed it on 99.7% of the items and voted against it 22 times. Its most frequent area of disagreement was corporate governance (9 of its votes against management). It voted on 21 shareholder proposals. It voted FOR the board's own proposals less often than WisdomTree's funds as a whole (89.2% against 91.6%). It voted the same way as most WisdomTree funds on every item where a comparison was possible. 6 of its meetings were contested.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of WisdomTree’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.